Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 31 studies with search of: | "Gastrinoma" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
21 | Completed |
Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas
|
||||
22 | Active, not recruiting |
Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery
|
||||
23 | Active, not recruiting |
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
|
||||
24 | Withdrawn |
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
|
||||
25 | Active, not recruiting |
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
|
||||
26 | Recruiting |
Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors
|
||||
27 | Active, not recruiting |
CCI-779 in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
|
||||
28 | Recruiting |
Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors
|
||||
29 | Not yet recruiting |
Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors
|
||||
30 | Active, not recruiting |
Sorafenib and Bevacizumab in Treating Patients With Refractory, Metastatic, or Unresectable Solid Tumors
|
||||
31 | Completed |
PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors
|
Previous Page (1-20) | Studies Shown (21-31) | Next Page |